noscript

IPO IPO Synopsis

 
Indo US Bio-Tech Ltd

Public issue of 14,30,000 equity shares of face value of Rs. 10 each of Indo Us Bio-Tech Limited ("Indo Us" or The "Company" or The "Issuer") for cash at a price of Rs. 51 per equity share including a share premium of Rs. 41 per equity share (The "Issue Price") aggregating to Rs. 7.29 crores ("The Issue"), of which 74,000 equity shares of face value of Rs. 10 each for cash at a price of Rs. 51 per equity share including a share premium of Rs. 41 per equity share aggregating to Rs. 0.38 crores will be reserved for subscription by market maker to the issue (The "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. Net issue of 13,56,000 equity shares of face value of Rs. 10 each at a price of Rs. 51 per equity share including a share premium of Rs. 41 per equity share aggregating to Rs. 6.91 crores is herein after referred to as the "net issue". The issue and the net issue will constitute 29.46% and 27.93% respectively of the post issue paid up equity share capital of the company. The Face value of the equity shares is Rs. 10 each and the issue price is Rs. 51. The Issue price is 5.1 times of the face value.
Opens On Closes On
Issue 30-Apr-18 03-May-18
Application Allotment
Money Payable On 51.00 0.00
Minimum Application for shares in Nos : 2000 Further Multiples of : 2000
  rupeeCr Lead Managers to the Issue
Project Cost (rupee.Cr) 7.29 Swastika Investmart Ltd
Project Financed through Current Offer (rupee.Cr) 7.29  
Post Issue Equity Share Capital (rupee.Cr) 4.85
Issue Price (rupee) 51.00
Projects
Incremental working capital
General corporate purpose
Promoted By
Jagdish Ajudia
Listing At
BSE - SME
Registrar to the Issue
Bigshare Services Pvt Ltd
Minimum Application for shares in Nos : Further Multiples of :
Attention Investors:
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. Prevent Unauthorized Transactions in your Demat account\Trading account: Update your Mobile Number with your Depository Participant\Exchange. Receive alerts on your Registered Mobile for all debit and other important transactions in your Demat account\Trading account directly from Depository\Exchange on the same day.........issued in the interest of investors.
Disclosure of Proprietary Account Trading by Members to Clients
Proprietary Trading Disclosure:In terms of provisions of the Rules, Bye-Laws and Business Rules of the Exchange and with reference to circular MCX/T&S/147/2016 dated May 17, 2016 regarding Disclosure of Proprietary Account Trading by broker to client.,Pursuant to SEBI Circular Number SEBI/MRD/SEC/Cir-42/2003 dated November 19, 2003 & SEBI/HO/CDMRD/DMP/CIR/P/2016/49 dated April 25, 2016 GOODWILL WEALTH MANAGEMENT PVT LTD, GOODWILL COMTRADES PVT LTD. Discloses to its clients about its policies on proprietary trades. Goodwill does proprietary trading in the derivatives segment at MCX respectively.GOODWILL – SEBI Reg No. INZ000049087
Copyright © 2016 All rights Reserved GOODWILL
Designed, Developed and content powered by CMOTS Infotech ( ISO 9001:2015 certified )